- OUTLOOK
The complex relationship between drugs and the microbiome
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 577, S10-S11 (2020)
doi: https://doi.org/10.1038/d41586-020-00196-0
This article is part of Nature Outlook: The gut microbiome, an editorially independent supplement produced with the financial support of third parties. About this content.
References
Ridker, P. M. et al. Eur. Heart J. 37, 1373–1379 (2016).
Maier, L. et al. Nature 555, 623–628 (2018).
Zimmermann, M. et al. Nature 570, 462–467 (2019).
Kelly, J. R. et al. J. Psych. Res. 82, 109–118 (2016).
Rekdal, V. M. et al. Science 364, eaau6323 (2019).
Haiser, H. J. et al. Science 341, 295–298 (2013)
The hunt for a healthy microbiome
Homing in on the molecules from microbes
Could a bacteria-stuffed pill cure autoimmune diseases?
Could the gut microbiome be linked to autism?
Fighting cancer with microbes
Rich data sets could end costly drug discovery
Therapeutic microbes to tackle disease
Diet should be a tool for researchers, not a treatment
Highlights from studies on the gut microbiome
